Switch to a biosimilar: Whatever the cost?

Joint Bone Spine. 2018 Dec;85(6):651-654. doi: 10.1016/j.jbspin.2018.09.007. Epub 2018 Sep 20.
No abstract available

Keywords: Biologic; Biosimilars; Cost containment; Interchangeability; Rheumatoid arthritis; Spondylarthritis; Switch.

Publication types

  • Editorial

MeSH terms

  • Arthritis, Rheumatoid / drug therapy*
  • Biosimilar Pharmaceuticals / economics
  • Biosimilar Pharmaceuticals / pharmacology*
  • Drug Costs*
  • Drug Substitution
  • Humans

Substances

  • Biosimilar Pharmaceuticals